NCT02705105 2024-04-25Study of Mogamulizumab + Nivolumab in Subjects w/Locally Advanced or Metastatic Solid TumorsKyowa Kirin Co., Ltd.Phase 1/2 Completed114 enrolled 19 charts
NCT02867007 2024-04-25KHK2455 Alone and in Combination With Mogamulizumab in Subjects With Locally Advanced or Metastatic Solid TumorsKyowa Kirin Co., Ltd.Phase 1 Completed36 enrolled